Advances in quality of life measurements in oncology patients

Seminars in Oncology

Volumn 29, Issue 3 SUPPL. 8, 2002, Pages 60-68

  Cella, David ^a   Chang, Chih Hung ^a   Lai, Jin Shei ^a   Webster, Kimberly ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT;

ACCURACY; CANCER PATIENT; CONFERENCE PAPER; EMOTIONAL STABILITY; FITNESS; FUNCTIONAL ASSESSMENT; HEALTH STATUS; HUMAN; INSTRUMENT; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL ASPECT; TUMOR REGRESSION; VALIDATION PROCESS; WELLBEING;

EID: 0036298098     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0093-7754(02)70176-0     Document Type: Conference Paper

References (54)

1. Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument
2. Quality of life for breast cancer patients receiving adjuvant chemotherapy
3. Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer
4. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection
5. The sickness impact profile: Development and final revision of a health status measure
6. Evaluation of impairment of health related quality of life in asthma: Development of a questionnaire for use in clinical trials
7. A measure of quality of life for clinical trials in chronic lung disease
8. Responsiveness and validity in health status measurement: A clarification
9. A new measure of health status for clinical trials in inflammatory bowel disease
10. Development and testing of a new measure of health status for clinical trials in heart failure
11. Measuring functional status in chronic lung disease: Conclusions from a randomized control trial
12. Measuring quality of life in clinical trials: A taxonomy and review
13. The MOS 36 Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs
14. The Nottingham Health Profile: Subjective health status and medical consultations
15. Measurement of health state utilities for economic appraisal
16. Stability of utilities in survivors of myocardial infarction
17. Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving hemodialysis
18. A model of health status for rheumatoid arthritis. A factor analysis of the Arthritis Impact Measurement Scales
19. Validation of the functional assessment of multiple sclerosis quality of life instrument
20. Measurement of pain by subjective report
21. Quality of Life Enjoyment and Satisfaction Questionnaire: A new measure
22. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association
23. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: First results from a three-country field study
24. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C 30
25. The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
26. A modular questionnaire for the assessment of long term quality of life in leukaemia patients: The MRC/EORTC QLQ-LEU
27. Quality of life evaluation by the EORTC questionnaire technique in patients with generalized malignant melanoma on chemotherapy
28. Criterion-based validation of the EORTC QLQ-C36 in advanced melanoma: The CIPS questionnaire and proxy raters
29. The EORTC QLQ-LC13: A modular supplement to the EORTC Core Quality of Life Questionnaire (QLQ-C30) for use in lung cancer clinical trials
30. The Functional Assessment of Cancer Therapy-Anemia (FACT-An) Scale: A new tool for the assessment of outcomes in cancer anemia and fatigue
31. Assessment of quality-of-life outcomes
32. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology
33. The Functional Assessment of Cancer Therapy (FACT) scale: Development and validation of the general measure
34. Comparison of two quality-of-life instruments for cancer patients: The Functional Assessment of Cancer Therapy-General and the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-C 30
35. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38)
36. Development of an EORTC questionnaire module to be used in quality of life assessment for patients with esophageal cancer
37. Development of an EORTC module to improve quality of life assessment in patients with gastric cancer
38. Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C 30 in patients with pancreatic cancer
39. Assessing quality of life in patients with head and neck cancer: Cross-validation of the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Head and Neck module (QLQ-H&N35)
40. Development of a European Organization for Research and Treatment of Cancer (EORTC) questionnaire module to be used in quality of life assessments in head and neck cancer patients
41. Quality of life in head and neck cancer patients: Validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N 35
42. Psychometric validation of the EORTC Core Quality of Life Questionnaire, 30-item version and a diagnosis-specific module for head and neck cancer patients
43. Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma
44. Assessment methods for quality of life in cancer patients: EORTC
45. Assessment methods for quality of life in cancer patients: The FACIT measurement system
46. Cross-language validation of the Functional Assessment of Cancer Therapy - Anemia questionnaire
47. International adaptation of the Functional Assessment of Chronic Illness Therapy (FACIT) quality of life questionnaires
48. A discussion of item response theory (IRT) and its applications in health status assessment
49. Item banking to improve, shorten and computerize self-reported fatigue
50. Quality-of-life benefit in chemotherapy patients treated with epoetin alfa is independent of disease response or tumor type: Results from a prospective community oncology study
51. Fatigue in cancer patients compared to that of the general United States population